Stock TCNNF TRULIEVE CANNABIS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Trulieve Cannabis Corp. OTC Markets

Equities

TCNNF

CA89788C1041

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 01:29:52 17/05/2024 am IST 		5-day change 1st Jan Change
12.48 USD +4.70% Intraday chart for Trulieve Cannabis Corp. +15.64% +139.54%
16/05 Pot stocks rise as US unveils proposal to ease restrictions on marijuana RE
10/05 Trulieve to Open Medical Cannabis Dispensary in Stuart, Florida CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,305 3,774 4,776 1,407 961.6 2,232 - -
Enterprise Value (EV) 1 1,346 3,727 4,763 2,020 961.6 2,388 2,229 1,658
P/E ratio 7.68 x 59.5 x 217 x -5.78 x -1.85 x -26.9 x -62.7 x 46.7 x
Yield - - - - - - - -
Capitalization / Revenue 5.16 x 7.24 x 5.09 x 1.13 x 0.85 x 1.88 x 1.79 x 1.83 x
EV / Revenue 5.32 x 7.15 x 5.08 x 1.63 x 0.85 x 2.01 x 1.79 x 1.36 x
EV / EBITDA 10.2 x 14.9 x 12.4 x 5.05 x 2.98 x 6.39 x 5.94 x 4.5 x
EV / FCF -26.3 x -80.6 x -18.1 x -12.7 x - 11.4 x 12.1 x 10.6 x
FCF Yield -3.8% -1.24% -5.52% -7.9% - 8.78% 8.29% 9.41%
Price to Book 4.83 x 8.34 x 1.78 x 0.74 x - 1.73 x - -
Nbr of stocks (in thousands) 1,10,346 1,19,579 1,83,507 1,85,934 1,86,113 1,87,290 - -
Reference price 2 11.82 31.56 26.03 7.567 5.167 11.92 11.92 11.92
Announcement Date 08/04/20 23/03/21 30/03/22 08/03/23 29/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 252.8 521.5 938.4 1,240 1,129 1,186 1,244 1,220
EBITDA 1 132.5 251 384.6 400.1 322.3 373.9 375.6 368.1
EBIT 1 124.1 226.8 336.5 280.7 144.7 169.4 189.1 189.3
Operating Margin 49.09% 43.49% 35.86% 22.64% 12.81% 14.29% 15.21% 15.52%
Earnings before Tax (EBT) 1 272.5 157.4 163.5 -43.3 -284.5 95.33 136.1 180.5
Net income 1 178 63 18 -246.1 -526.8 -78 -32.7 72.95
Net margin 70.42% 12.08% 1.92% -19.85% -46.65% -6.58% -2.63% 5.98%
EPS 2 1.540 0.5300 0.1200 -1.310 -2.790 -0.4438 -0.1900 0.2550
Free Cash Flow 1 -51.19 -46.22 -263 -159.6 - 209.8 184.9 156
FCF margin -20.25% -8.86% -28.03% -12.87% - 17.7% 14.87% 12.79%
FCF Conversion (EBITDA) - - - - - 56.11% 49.23% 42.38%
FCF Conversion (Net income) - - - - - - - 213.85%
Dividend per Share - - - - - - - -
Announcement Date 08/04/20 23/03/21 30/03/22 08/03/23 29/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 305.3 318.3 320.3 300.8 302 289.1 281.8 275.2 287 297.6 293.5 294.3 301.4 303.6 308.4
EBITDA 1 100.9 105.5 111 98.76 84.7 78.2 79 77.7 87.8 105.8 88.95 88.04 89.27 94.36 95.24
EBIT 1 72.6 76.2 80.1 68.57 54 31.8 36.1 31.6 42.9 59.3 44.72 42.1 42.62 - -
Operating Margin 23.78% 23.94% 25.01% 22.8% 17.88% 11% 12.81% 11.48% 14.95% 19.93% 15.23% 14.31% 14.14% - -
Earnings before Tax (EBT) 1 -31.32 9.834 20.75 -48.81 -30.8 -30.7 -308.3 13.7 8.8 31.9 22.56 21.39 22.74 23.8 23.29
Net income 1 -71.5 -32 -22.5 -114.6 -77 -64.1 -403.8 -25.4 -33.4 -23.1 -19.19 -20.16 -19.49 -19.75 -20.08
Net margin -23.42% -10.05% -7.02% -38.08% -25.5% -22.17% -143.29% -9.23% -11.64% -7.76% -6.54% -6.85% -6.47% -6.5% -6.51%
EPS 2 -0.5600 -0.1700 -0.1200 -0.6100 -0.4100 -0.3400 -2.140 -0.1400 -0.1800 -0.1200 -0.1088 -0.1125 -0.1075 -0.1050 -0.1050
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 30/03/22 12/05/22 10/08/22 09/11/22 08/03/23 10/05/23 09/08/23 09/11/23 29/02/24 09/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 41.4 - - 613 - 157 - -
Net Cash position 1 - 46.7 13.8 - - - 2.68 574
Leverage (Debt/EBITDA) 0.3127 x - - 1.532 x - 0.4185 x - -
Free Cash Flow 1 -51.2 -46.2 -263 -160 - 210 185 156
ROE (net income / shareholders' equity) 92.1% 21.7% 9.52% -1.48% - -7.5% -3.9% -
ROA (Net income/ Total Assets) 47.3% 10.5% 21.4% -0.88% - -3.5% -1.7% -
Assets 1 376.5 601.1 83.99 27,843 - 2,229 1,923 -
Book Value Per Share 2 2.450 3.790 14.60 10.30 - 6.900 - -
Cash Flow per Share 2 0.2000 0.8400 0.0800 0.1200 - 0.5000 1.020 -
Capex 1 74.7 99.9 276 183 - 66.2 42.7 30.5
Capex / Sales 29.55% 19.16% 29.4% 14.74% - 5.58% 3.43% 2.5%
Announcement Date 08/04/20 23/03/21 30/03/22 08/03/23 29/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Trulieve Cannabis Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
12.49 USD
Average target price
17.61 USD
Spread / Average Target
+41.03%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Recreational Pharmaceuticals

1st Jan change Capi.
CURALEAF HOLDINGS, INC. Stock Curaleaf Holdings, Inc.
+40.11% 4.24B
GOODNESS GROWTH HOLDINGS, INC. Stock Goodness Growth Holdings, Inc.
+192.06% 84.17M
Recreational Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TRUL Stock
  4. TCNNF Stock
  5. Financials Trulieve Cannabis Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW